Melanotan I (Afamelanotide)
Compounding-legalAlso known as: Scenesse
FDA-approved α-MSH analog — pigmentation, EPP photoprotection.
Mechanism
α-MSH analog. FDA-approved α-MSH analog — pigmentation, EPP photoprotection. For full mechanism, dosing protocol, and stacking guidance, ask the AI Advisor or open the compound in-app.
Peer-Reviewed Studies (2)
Afamelanotide for Erythropoietic Protoporphyria
Phase 3 trial: significant photoprotection in EPP patients.
PubMed PMID 26039498 →Melanocortin Agonists in Pigmentation
Reviewed melanocortin pathway and pigmentation effects.
PubMed PMID 20455964 →